MDIC’s Health Economics and Patient Value Real World Evidence Forum gave attendants firsthand perspectives on how CMS, commercial payers, and industry are using real world evidence to drive coverage decision making and help pave the road to patient access. This solution-focused collaboration intended to advance the understanding and practical applications of real-world evidence among Payers and Industry.
Date: April 26, 2022 | 1:00 PM (ET) – 4:00 PM (ET)
Participants collaborated, conversed and advanced their knowledge in a solution-focused environment.
Welcome and Introduction
Pamela Goldberg
MDIC Health Economics and Patient Value Overview
Jo Carol Hiatt, MD, MBA, VP, Health Economics and Patient Value, MDIC
Industry Perspective on Importance of RWE for Coverage Decision Making
Philip B. Adamson, MD, MSc, FACC, FESC, FRCP (Ed) Chief Medical Officer, Heart Failure Division, Divisional Vice President, Abbott
Recommendations for Industry from The Lewin Group Landscape Assessment
Cliff Goodman, PhD, Senior VP, The Lewin Group
Key Takeaways and Practical Considerations: Assessment of CED Over Past 15 Years
Emily Zeitler, MD, MHS, Assistant Prof of Medicine, Geisel School of Medicine, Assistant Prof of Health Care Policy, The Dartmouth Institute, Dartmouth-Hitchcock Medical Center
Considerations in Development of Transitional Coverage for Emerging Technologies (TCET)
Steve Farmer, MD, Chief Strategy Officer for Coverage at Centers for Medicare and Medicaid Services (CMS)
Commercial Payer MedTech Case Study: Opportunities for Collaboration
Debra Reisenthel, Freespira, Inc., Vice Chair, Digital Therapeutics Alliance
Eileen Rodgers, Director, Highmark VITAL Innovations Program
Panel/Roundtable Discussion
Panelists:
Steve Farmer, MD, CMS
Charlie Viviano, MD, PhD, FDA
Philip B. Adamson, MD, CMO, Abbott
Emily Zeitler, MD, MHA
Robert N. Cuyler, PhD, Chief Clinical Officer, Freespira, Inc.
Moderators:
Jo Carol Hiatt, VP, MDIC and Kimberly L. Sterling, VP, ResMed
Wrap-up and Conclusion
Jo Carol Hiatt, MD, MBA, VP, Health Economics and Patient Value, MDIC
